Crestline Investors, Inc.

10% owner at DNLI; 10% owner at Juno Therapeutics, Inc.

Sold, on record
$680M
Dollars the filings state
Form 4 sales
4
Latest Jun 5, 2020
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Juno Therapeutics, Inc.Unusual
    Mar 1 2016

    Sold 8.6M shares at $39.00 ($335M)

    Crestline Investors, Inc., 10% owner

    Sold 33.4% of holdings ($1B position)17.2M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Juno Therapeutics, Inc.Unusual
    Jul 13 +499 days

    Sold 8M shares at $27.00 ($216M)

    Crestline Investors, Inc., 10% owner

    Sold 46.6% of holdings ($463M position)9.2M shares leftFiling

  3. 3 Form 4 sale DNLIPlan not stated
    Feb 26 +958 days

    Sold 3.9M shares at $20.25 ($78.9M)

    Crestline Investors, Inc., 10% owner

    Sold 20% of holdings ($394M position)15.6M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale DNLIPlan not stated
    Jun 5 +100 days

    Sold 1.9M shares at $25.75 ($49.5M)

    Crestline Investors, Inc., 10% owner

    Sold 12.4% of holdings ($401M position)13.6M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Crestline Investors, Inc.
Source
Jun 5, 2020DNLI10% ownerForm 4 sale1.9M$49.5M12.4%Plan not statedSEC
Feb 26, 2020DNLI10% ownerForm 4 sale3.9M$78.9M20.0%Plan not statedSEC
Jul 13, 2017Juno Therapeutics, Inc.10% ownerForm 4 sale8M$216M46.6%UnusualSEC
Mar 1, 2016Juno Therapeutics, Inc.10% ownerForm 4 sale8.6M$335M33.4%UnusualSEC